Novo-medicin slukker øltørsten – men Carlsberg har forberedt sig på slankebølge
Full story
Weight loss medications are reducing the desire for alcohol among users. Carlsberg has responded to this trend with a strategic shift. The company is focusing more on soft drinks and non-alcoholic beers. Executive Jacob Aarup-Andersen stated that these changes are intended to address the shift in consumer habits.
Den stigende brug af vægttabsmedicin mindsker lysten til alkohol. Men Carlsbergs omfattende strategiske skifte mod alkoholfrie øl og læskedrikke skal netop tage højde for de store forandringer, fortæller topchef Jacob Aarup-Andersen.